SSX genes show extensive nucleotide sequence conservation but little is known of their function. Disruption of SSX1 or SSX2, by chromosome translocation and`inframe' fusion to SYT, is a consistent feature of synovial sarcomas. The resulting SYT-SSX1/SSX2 proteins are activators of transcription; transactivation function is located in SYT. Unrearranged SSX1 can repress transcription, and this has been attributed to a putative KruÈ ppel associated box (KRAB) repression domain at the N-terminus. Here we isolated SSX-KRAB domains to speci®cally measure repression activity, using a previously characterized KOX1-KRAB domain as a control. In our repressor assay SSX1-and SSX2-KRAB domains down-modulated the transactivation of a reporter gene by threefold, compared with 83-fold repression achieved by KOX1-KRAB in the assay. Yeast two-hybrid analysis showed that SSX1-KRAB, unlike KOX1-KRAB, fails to interact with the KRAB corepressor TIF1b. These results raise questions about the evolutionary and functional relationship of SSX-KRAB and typical KRAB domains of KruÈ ppel zinc ®nger genes. We found that full-length SSX1 showed potent (74-fold) repression in our repressor assay, indicating the existence of a repression domain distinct from SSX-KRAB. By assaying deletion constructs of SSX1 we localized repression activity to 33 amino acids at the C-terminus. This novel domain is conserved between SSX family members, and, unlike the KRAB-related domain, is retained on fusion with SYT. This has important implications in understanding the mechanism by which the SYT-SSX fusion protein could contribute to neoplasia.
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Keywords: sarcoma; SSX; KRAB; transcription Chromosome translocation t(X;18)(p11.2;q11.2) (Clark et al., 1994; Crew et al., 1995) is a diagnostic feature of human synovial sarcomas, in some cases representing the sole cytogenetic abnormality (Sandberg and Bridge, 1994) . All the available evidence indicates that this translocation is a key event in tumorigenesis. In all tumours characterized, the SYT gene on chromosome 18 is juxtaposed`in-frame' with either the SSX1 gene or SSX2 gene on chromosome X (Figure 1 ). SSX1 and SSX2 are now known to be members of a highly conserved multigene family Gure et al., 1997) , and the SSX loci that have been mapped are all located in chromosome band Xp11.2 (Crew et al., 1995; . In contrast to SYT, which is a widely expressed gene (de Bruijn et al., 1996; J Knight., unpublished data) , SSX transcripts show a very restricted distribution in adult human tissues. So far, SSX1 and SSX2 expression has only been detected in testis and thyroid (Crew et al., 1995; Tureci et al., 1996; Gure et al., 1997) .
As yet, little is known about the normal biological functions of the SYT and SSX gene products. No DNA binding sequences are recognizable in the SYT or SSX proteins. However, when coupled to a GAL4 DNA binding domain in in vitro reporter assays, SYT can activate transcription (70-fold activation) and SSX1 can repress transcription (50-fold repression) from a minimal promoter in NIH3T3 ®broblasts (Brett et al., 1997) . Our studies (Soulez et al., manuscript submitted), and others, have revealed that SYT, SSX1, SSX2 and the fusion genes SYT-SSX1 and SYT-SSX2, encode nuclear proteins (Brett et al., 1997; dos Santos et al., 1997; Soulez et al., manuscript submitted) . Their localization to the cell nucleus provides further evidence of a role for these proteins in modulating gene transcription. This would be consistent with the observation that many of the genes disrupted by chromosome translocation in human sarcomas encode transcription factors, and that the fusion genes formed by such mutational events encode chimaeric transcription factors with aberrant activity (Sorensen and Triche, 1996) .
Correspondence: JC Knight Received 21 January 1998; revised 11 May 1998; accepted 11 May 1998 Figure 1 Schematic diagram of the most frequently detected form of the SYT-SSX chimaeric protein. The t(X;18) breakpoint juxtaposes the SYT and SSX genes. The point of fusion between the SYT gene and the SSX1 or SSX2 genes is identical. The translated protein comprises (aa 1 ± 379) SYT and (aa 111 ± 188) SSX (Crew et al., 1995) . The C-terminal eight amino acids of SYT are replaced by SSX. The SSX-KRAB domain is lost and replaced with SYT sequences containing a transcription activation domain. Transcripts of the reciprocal fusion gene are not detected (Clark et al., 1995) . There are no recognizable DNA binding domains in SYT or SSX In this study our objective was to carry out a detailed analysis of the transcription repression mediated by the SSX proteins. The SSX1 and SSX2 genes encode closely related proteins 188 amino acids in length and sharing 83% similarity of amino acid sequence. The predicted amino acid sequences of the SSX proteins are rich in charged amino acids arginine and lysine. They contain consensus sequences for Nglycosylation and tyrosine phosphorylation (Crew et al., 1995) , three putative bipartite nuclear localization signals (dos Santos et al., 1997) , and an acidic Cterminal domain (Crew et al., 1995) . The most striking feature is an N-terminal region with homology to the KruÈ ppel-associated box (KRAB) domain (Crew et al., 1995) (Figure 2) .
The KRAB domain is a highly charged 75 amino acid motif that de®nes a large sub-family of Cys2His2-type (KruÈ ppel-type) zinc ®nger DNA binding proteins, such as KOX1, which act as potent transcriptional repressors (Margolin et al., 1994; Pengue et al., 1994; Witzgall et al., 1994) . It can be further divided into two sub-domains, A and B (see Figure 2 ), which are predicted to fold into two amphipathic helices. The transcription repression domain has been delimited to a sequence of 45 amino acids within the KRAB A subdomain (Margolin et al., 1994) . Repression is DNA binding site-dependent and is dominant over activation when tethered to an activator. The KRAB B subdomain does not repress by itself but does potentiate the repression exerted by the KRAB A sub-domain (Vissing et al., 1995) .
The ®nding that the amphipathic helix of the typical KRAB A sub-domains of KruÈ ppel-type zinc ®nger proteins KOX1, ZNF2 and Kid-1 serves as an interface for interaction with a ubiquitously expressed corepressor molecule TIF1b (also called KAP1 or KRIP-1), has led to the proposal that KRAB repression is mediated via this pathway (Friedman et al., 1996; Kim et al., 1996; Moosmann et al., 1996) . TIF1b is structurally related to a transcription intermediary factor TIF1a (Le Douarin et al., 1995) , a member of the RBCC (RING ®nger-B boxes-Coiled Coil) subfamily of RING ®nger proteins containing a con®guration of a RING ®nger, B box(es) and a coiled-coil. The B boxes and coiled-coil domain of TIF1b are essential for interaction with the KRAB A sub-domain but the precise nature of the interaction is uncertain (Moosmann et al., 1996) .
The SSX-KRAB domains show greatest homology (39 ± 49%) to KRAB A and contain a high proportion of the amino acids which are usually conserved between the KRAB A domains of zinc ®nger proteins ( Figure 2 ) (Crew et al., 1995) . In all the SYT-SSX1 and SYT-SSX2 fusion transcripts analysed, this KRAB domain is deleted and replaced with SYT sequence (see Figure 1) . Transcripts of the reciprocal SSX-SYT fusion gene, which would be predicted to juxtapose the SSX-KRAB domain with the C-terminal eight amino acids of SYT (see Figure 1 ), are not detectable (Clark et al., 1994) . Brett et al., (1997) have reported that full-length SSX1 exerts transcriptional repression and attribute this to the KRAB domain. To date the SSX-KRAB domain itself has not been tested for repression activity. In this study we have used a highly sensitive transcription repressor assay (TRA) ®rst described by Thiesen (1997) to assess the potential dominant repression eect of protein domains fused to a potent transcriptional activator GAL4-VP16 (Sadowski et al., 1988) .
To test the KRAB domains of SSX1 and SSX2 in the TRA system, we transferred amino acids 18 ± 83 (containing the KRAB domain) of SSX1 and SSX2 to the C-terminus of GAL4-VP16. Expression constructs ( Figure 3a ) and reporter constructs ( Figure 3b ) were co-transfected into HeLa cells, and repression was measured as a percentage of maximal GAL4-VP16 activated transcription. As a positive control we screened a GAL4-VP16-KRAB fusion protein, containing a well characterized KRAB repression domain derived from KOX1 (Margolin et al., 1994) . The KRAB domains of other zinc ®nger proteins show similar results to KOX1 in the TRA system (H-J Thiesen, unpublished data). A GAL4-VP16-KRAB B fusion protein, lacking KRAB A sequences, served as a negative control. All results were normalized for transfection eciency, and the fusion proteins used in these experiments were expressed at similar levels as determined by immunoblotting analysis (data not Figure 2 Alignment of the SSX KRAB-homologous domains with the KOX1-KRAB domain. Based on sequence data provided by (Crew et al., 1995; Gure et al., 1997) . Identity to SSX1 is indicated with a {.}, and {*} indicates a gap of one amino acid used to optimize alignment with KOX1. Consensus SSX sequence is shown at the bottom of the ®gure: upper case indicates total conservation, lower case indicates the predominant amino acid in that position, and {-} indicates no clear consensus. A {*} indicates that the amino acid in that position is conserved between SSX1 to SSX5 and KOX1. The mutations DV?AA and MLE?KKK, which reduce the ability of KOX1-KRAB to repress transcription (Margolin et al., 1994) by abolishing interaction with the corepressor TIF1b (Moosmann et al., 1996) are indicated shown). As expected, VP16-induced transcriptional activation of the luciferase reporter was almost totally repressed (483-fold repression) by the KOX1-KRAB domain. The SSX1-and SSX2-KRAB domains reduced VP16-induced reporter gene activation to 28% (3.5-fold repression) and 30% (3.3-fold repression) of maximal activity respectively (Figure 3c,d) . Assay results were similar regardless of orientation of the GAL4 DNA binding domain. Thus, our results appear to suggest that the KRAB domains (including A and B sub-domains) of SSX proteins can down-modulate VP16-induced transcriptional activation when tethered to a DNA-bound activator. However, the level of repression we observed was only comparable with that of a mutant form of KOX1-KRAB, KOX1 (1 ± 73) MLE, which reduced VP16-induced activation to an average of 20% of maximum (®vefold repression) (Figure 3) .
The repression activity exerted by the KOX1 MLE mutant is reduced by speci®c point mutations in KRAB A that substitute the sequence MLE with KKK (MLE?KKK) as indicated in Figure 2 (Margolin et al., 1994; Thiesen, 1997) . The leucine residue in the MLE sequence occurs in the context of the highly conserved VMLENY motif common to almost all KRAB A sub-domains, and is one of the heptad repeats of leucines (MX6LX6LX6L, where X is any amino acid) capable of forming an amphipathic helix (Thiesen, 1990) . Disruption of the heptad repeat of leucines in KRAB A compromises the level of repression exerted. Secondary structure predictions calculate a high probability that the SSX-KRAB domains could adopt a two-helix structure, but the ®ve heptad repeats of leucines are absent. The VMLENY sequence is replaced by YMKRNY in SSX1, and YMKRKY in SSX2, both sequences mimicking the basic residues present in the KOX1 MLE?KKK mutant. The dierence in the ability of SSX-KRAB compared with KOX1-KRAB to repress activated transcription might therefore be attributable to structural dierences in the KRAB A domain, which could alter interaction with the KRAB co-repressor TIF1b. Earlier studies have reported that the KOX1-KRAB domain mutants DV?AA (Friedman et al., 1996) and MLE?KKK (Moosmann et al., 1996) (see Figure 2) , which have reduced abilities to repress transcription, fail to interact with TIF1b.
To test whether SSX proteins interact with TIF1b, we set up a yeast two-hybrid assay using full-length SSX1 (aa 1 ± 188) or SSX1-KRAB domain (aa 1 ± 119) fused to the LexA DNA-binding domain as the bait, and TIF1b (aa 71 ± 483) as fusion GAL4-transactivation target (gift of W Schaner). Moosmann et al., (1996) have previously shown that this TIF1b (aa 71 ± 483) target, which spans the B boxes, and coiled-coil domain, interacts most strongly with KOX1-KRAB compared to other TIF1b constructs tested. By using this truncated form of TIF1b, we expected to maximize the possibility of detecting an interaction with SSX1. As a positive control bait construct, we used the KOX1-KRAB domain (aa 1 ± 122) fused to the LexA DNA-binding domain. We detected strong interaction between this KOX1-KRAB bait and the TIF1b target in yeast, as seen from the growth of the yeast transformants in histidine-de®cient media and the detection of b-galactosidase activity in these transfor- The backbone plasmid for expression of fusion proteins was pM3-VP16-FLAG, derived from mammalian expression vector pM3 (Sadowski et al., 1992) . The expressed fusion protein contains the N-terminus (amino acids 1 ± 147) of GAL4 (the DNA binding domain), and four copies of the VP16 activation domain. The 8-residue FLAG marker peptide (IBI Ltd) was cloned`in-frame' with the C-terminus of the pM3-VP16. Sequences containing the KRAB domains to be tested for repressor activity were ampli®ed by PCR from cDNA clones of KOX1, mutant KOX1 containing amino acid substitution MLE?KKK, SSX1 and SSX2, and fused in-frame to the pM3-VP16-FLAG background as depicted. All clones were veri®ed by sequencing. The level of expression and size of each fusion protein was con®rmed by SDS ± PAGE and immunoblotting analysis using anti-FLAG M2 monoclonal antibody (IBI Ltd). (b) Schematic diagram of the luciferase reporter plasmid pGL2 (GAL+ or GAL7orientation). The luciferase reporter was constructed by inserting ®ve tandem repeats of synthetic GAL4-binding sites in + or7orientation, upstream of the SV40 promoter in the pGL2 vector (Promega). These are designated pGL2 (GAL+) and pGL2 (GAL7). HeLa cells seeded at 1610 5 cells per 60 mm plate were transfected with 1mg of pGL2 reporter, 1 mg of GAL4-VP16 expression construct and 1 mg of a control b-galactosidase reporter plasmid. After 48 h, cell extracts were assayed for luciferase and b-galactosidase activities. (c) Percent activation (+standard error) of pGL2 is shown. Luciferase activities were normalized against b-galactosidase activities to adjust for variations in transfection eciency. Duplicate transfections for each GAL4-VP16 construct were performed, and each experiment was performed at least three times. The level of activation of the GAL4-VP16 construct alone is assigned the value of 100%, and activation achieved by the test constructs are expressed as a percentage of this value. Results from control experiments using a pGL2 reporter construct without GAL4-binding sites (pGL2 control) are also shown. (d) The data represented as a histogram mants (Figure 4) . Using the same criteria we saw no evidence of interaction between the SSX1 bait (either full-length or KRAB domain alone) and TIF1b target in yeast (Figure 4) . On the basis of these results, we conclude that the SSX-KRAB does not function through TIF1b. Brett et al. (1997) have shown previously that fulllength SSX1 can repress transcription 50-fold from a tk promoter. They also brie¯y noted that the SYT-SSX2 fusion (SYT-SSX1 was not tested) had a reduced capacity to activate a tk promoter compared to unrearranged SYT. When we tethered full-length SSX1 to VP16 in our TRA system, we observed a 74-fold repression of VP16 activity, which is much stronger than with SSX1-KRAB alone (3.5-fold) ( Figure 5 ). This prompted us to search for additional sequences in SSX proteins that might have the capacity to repress transcription. We considered a highly conserved motif of 33 amino acids, located at the Cterminus (residues 155 ± 188) in each of the ®ve SSX family members described to date (Crew et al., 1995; Gure et al., 1997) , to potentially be a domain of functional signi®cance (Figure 5d ). Figure   5a illustrates the series of SSX1-GAL4-VP16 fusion proteins that we designed and tested in our TRA reporter system in HeLa cells. From the analysis of these deletion constructs we delimited the repressor activity to the conserved domain (residues 155 ± 188) at the C-terminus, which we call the SSXRD (SSX Repression Domain). The potent repression exerted by full-length SSX1 appears to localize to this region (Figure 5b and c) . The GAL4-VP16-SSX1 (aa 122 ± 162) fusion protein lacking both the KRAB and SSXRD regions, allowed strong activation of the reporter gene with little evidence of interference with VP16 transactivation (Figure 5b and c) . Immunoblotting analysis showed that the GAL4-VP16 constructs containing SSX1 (aa 122 ± 162) and SSXRD (SSX1 aa 155 ± 188) are expressed at similar levels, indicating that the observed result was not simply due to a dierence in the expression levels or stability of these proteins (Figure 5e ). We have also con®rmed these results in two additional mammalian cell lines COS7 and the synovial sarcoma line CME1 (Renwick et al., 1995) (data not shown). When the SSXRD (SSX1 aa 155 ± 188) was tethered directly to the GAL4 DNA binding a b Figure 4 SSX1 does not interact with TIF1b. (a) Yeast two-hybrid assays using full-length SSX1 (pHybLex/zeo-SSX1 aa 1 ± 188) or SSX1-KRAB domain (pHybLex/zeo-SSX1 aa 1 ± 119) as bait showed no interaction with the TIF1b target (pACT-TIF1b aa 71 ± 483). Transformed yeast (strain L40) colonies lifted onto nitrocellulose membrane did not show b-galactosidase activity (no blue coloration). Transformants from the positive control, using KOX1-KRAB domain (pHybLex/zeo-KOX1 aa 1 ± 122) as bait, showed b-galactosidase activity (blue colonies on ®lter assay), indicating interaction with the TIF1b target (pACT-TIF1b aa 71 ± 483). Expression of the bait plasmids in the transformants was con®rmed (data not shown) by SDS ± PAGE and immunoblotting analysis with anti-LexA polyclonal antibody (Invitrogen). (b) Test for histidine prototrophy. Only transformants from the positive control grew on media lacking histidine. Control experiments (omitting pAct-TIF1b) in which the bait plasmids alone were transformed into L40, did not confer ability to grow on histidine-de®cient media. Bait constructs of full-length SSX1, SSX1-KRAB and KOX1-KRAB were made by PCR ampli®cation of cloned cDNA, followed by in-frame insertion into the yeast expression plasmid pHybLex/Zeo (Invitrogen). All clones were veri®ed by sequencing domain, it was also able to repress basal transcription, albeit to a smaller extent (approximately twofold), whereas the GAL4-SSX1 (aa 122 ± 162) fusion protein lacking both the KRAB and SSXRD regions showed little evidence of interference with basal transcription of the SV40 promoter (Figure 6 ).
Although the SSXRD is conserved at the amino acid level (593%) in all ®ve members of the gene family, and is predicted to fold into an alpha helix, it does not share homology with known protein domains in the ProDom database within SwissProt (Gish, 1994 (Gish, ± 1997 . BLAST (Altschul et al., 1990) and FASTA (Pearson and Lipman, 1988 ) searches also did not reveal extensive similarities between the SSXRD and protein translations of DNA sequences in the Genbank/EMBL data bank. We do not yet know if the SSXRD exerts its eect directly or via interaction with a co-repressor, but the search for protein targets is clearly a priority.
We have therefore identi®ed a novel functional domain at the C-terminus of SSX proteins, the SSXRD, which when tethered to DNA can repress basal transcription and exert stronger repression over VP16-induced activation than the SSX-KRAB domain. This domain is retained on the SYT-SSX1 and SYT-SSX2 chimaeric genes expressed in synovial sarcomas (see Figure 1) .
Our work raises interesting questions about the evolutionary and functional relationship of the SSX gene family and KruÈ ppel-type zinc ®nger genes. The human SSX genes comprise six exons and ®ve introns spanning at least 8 kb (Gure et al., 1997) . In spite of apparent functional variance, the intron/exon organization nevertheless provides evidence of structural relationship to the KruÈ ppel-type zinc ®nger gene family. In those zinc ®nger genes characterized (ZNF2, KOX1), KRAB A and KRAB B are encoded by two separate exons (Rosati et al., 1991; D Koczan., unpublished data) . Interestingly, a similar organization is seen in SSX genes, and furthermore the intron The SSXRD represses basal transcription from the SV40 promoter. SSX1 sequences (see Figure 5a ) fused C-terminal to the GAL4 DNA-binding domain in a pM3-FLAG background were tested in gene reporter assays in HeLa cells. pGL2 reporter plasmids are shown in Figure 3b . The expression and size of each fusion protein was con®rmed by immunoblotting (see legend to Figure 3 ). The level of activation of the reporter achieved by a GAL4-VP16 construct is assigned the value of 100%, and activation achieved by the test constructs is expressed as a percentage (+standard error) of this value. Results from control experiments using a pGL2 reporter construct without GAL4-binding sites (pGL2 control) are also shown separating the two boxes A and B, spans approximately 700 nucleotides in both SSX1 and KOX1 (J Knight and D Koczan, unpublished data) . This similarity in genomic organization raises the possibility that the SSX KRAB-related domain and the typical KRAB domains of KruÈ ppel zinc ®nger genes could share a common ancestry. The KRAB domains in SSX genes may represent a gain of function or loss of function permutation of the typical KRAB sequence of zinc ®nger genes. At present we have no reason to implicate SSX-KRAB in the pathogenesis of synovial sarcoma, because this domain is absent from the transcripts of SYT-SSX1 and SYT-SSX2 expressed in synovial sarcomas (Figure 1) . We suggest that SSX-KRAB domains constitute a variant of typical KRAB, that probably act as a protein-protein interaction interface, but which require further investigation to clarify whether they have a role in mediating transcription repression. This is the ®rst systematic analysis of SSX function. We have used the TRA system to characterize the SSX-KRAB domain and to de®ne a potent transcription repression domain, the SSXRD, highly conserved at the C-terminus of SSX proteins that is retained in the SYT-SSX fusion proteins. The t(X;18) chromosome translocation juxtaposes SSX1 or SSX2 with SYT, the wild-type form of which behaves as a transcriptional activator in gene reporter assays. Brett et al. (1997) observed that the ability of SYT-SSX2 (SYT-SSX1 was not reported) to activate transcription of the tk promoter was lower than that achieved by unrearranged SYT in parallel experiments. Our results now provide a possible explanation for this. The SSXRD can exert repression over transcription activation in the gene reporter assay we have described. By analogy to the VP16-SSX fusion protein constructs described here, we suggest that the potential of SYT to activate a promoter is modulated by the activity of the SSXRD fused to its C-terminus. This has important implications in understanding the mechanism by which the SYT-SSX1 and SYT-SSX2 fusion proteins could contribute to neoplasia. We are currently investigating how the dual roles of transcription activation and repression acquired by SYT-SSX1 and SYT-SSX2 contribute to perturbation of cell function and to neoplasia.
